FDA inspection
PharmaBlock Pharmaceuticals (Zhejiang) Co., Ltd: FDA inspection ending Jul 5, 2019
FDA inspection 1099563 · No Action Indicated (NAI) · Shaoxing
Key facts
| Inspection ID | 1099563 |
|---|---|
| Firm | PharmaBlock Pharmaceuticals (Zhejiang) Co., Ltd |
| FEI number | 3003005071 |
| Address | Shangyu Economic And Technological, No. 11 Weiqi Road, Hangzhou Bay; Development Area |
| City | Shaoxing |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Jul 5, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data